World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ISRCTN
Last refreshed on: 3 April 2017
Main ID:  ISRCTN51523311
Date of registration: 21/07/2016
Prospective Registration: No
Primary sponsor: Landseed Hospital
Public title: The effectiveness of intensive chest physiotherapy for patients on mechanical ventilation in ICU
Scientific title: Chest physiotherapy to improve extubation outcomes for critically ill patients with mechanical ventilation in ICU
Date of first enrolment: 24/10/2014
Target sample size: 437
Recruitment status: Completed
URL:  http://isrctn.com/ISRCTN51523311
Study type:  Interventional
Study design:  Single-centre prospective non-randomised study with retrospective case-note review (Treatment)  
Phase: 
Countries of recruitment
Taiwan
Contacts
Name:    
Address: 
Telephone:
Email:
Affiliation: 
Name: Tsung-Hsien    Wang
Address:  Landseed Hospital No.77, Guangtai Road Pingzhen District 32449 Taoyuan City Taiwan
Telephone: +886 (0)3 4945353
Email: d03428002@ntu.edu.tw
Affiliation: 
Key inclusion & exclusion criteria
Inclusion criteria: 1. Aged 18 years and over
2. Admitted to the Landseed Hospital Intensive Care Unit
3. Require mechanical ventilation for at least 48 hours

Exclusion criteria: 1. Brain death patients
2. Ventilator-dependent patients
3. Tracheostomy patients
4. Patients receiving hospice care
5. Patients that have transferred during treatment


Age minimum:
Age maximum:
Gender: Both
Health Condition(s) or Problem(s) studied
Patients requiring mechanical ventilation
Respiratory
Intervention(s)
Two groups of participants take part in this study.

Control group: Patients who previously received standard nursing care have their case notes from 2015 reviewed for extubation outcomes, mortality, hosptial transfers and clinic data (such as clinical diagnosis, Glasgow coma score, heart rate, blood pressure, respiratory rate, tidal volume,RSBI, length of stay, duration of mechanical ventilation and secretion volume). The results of this are then compared to the intervention group.

Intervention group: Participants take part in a a chest physiotherapy program, which consists of inspiratory muscle training, manual hyperinflation, chest wall mobilization, rib-cage compression, posture drainage, secretion removal, cough function training, extremity range of motion exercise.
Rib cage compression consists of producing mechanical force transferred through the chest wall into the airways during the expiratory phase for the purpose of increasing and redirecting air flow, for pulmonary re-expansion and airway clearance.
Manual hyperinflation was performed using a manual hyperinflation device with inspiratory pressure 40 cm H2O and FIO2 at 0.6, inducing a tidal volume increase and generating subsequent improvement in pulmonary compliance, inspiratory flow, and bronchial secretion clearance.
During implementation of the techniques, SpO2 , heart rate, breathing frequency, and mean arterial pressure were monitored to control the effects while the protocol was performed.
Early mobilization were also given by the physiotherapist according to patients’ conditions, vital signs, and clinical performance. These exercises started with sitting on the edge of the bed for moving their limbs, training for standing on their own, and moving off the bed to sit in a chair.
Treatment takes place in 30-40 minute sessions once a day, five times a week, and treatments were given until the patient was discharged from the ICU.
Extubation outcomes are determined according to observations by the at
Primary Outcome(s)
Extubation outcomes are determined by the attending physician observations (taken from medical records for control participants):
1. Extubation failure rate, defiened as the need for reintubation within 72 hours after extubation
2. Extubation rate, is calculated as extubation failure participants divided by all participants
Secondary Outcome(s)
Rapid Shallow Breathing Index is measured using a handheld spirometer attached to the endotracheal tube while the patient breathes room air for one minute without any ventilator assistance in the intervention group, and taken from medical records for control participants.
Secondary ID(s)
N/A
Source(s) of Monetary Support
Landseed Hospital
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history